We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+45.29%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$483M
AUM Growth
+$23M
(+5%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
9.87%
Holding
378
New
132
Increased
14
Reduced
97
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLX Energy Services
KLXE
|
+$3.31M |
| 2 |
Par Pacific Holdings
PARR
|
+$3.1M |
| 3 |
A10 Networks
ATEN
|
+$3.05M |
| 4 |
Federal Signal
FSS
|
+$2.71M |
| 5 |
Tidewater
TDW
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.93M |
| 2 |
Cogent Biosciences
COGT
|
+$5.04M |
| 3 |
Lantheus
LNTH
|
+$4.84M |
| 4 |
Sensus Healthcare
SRTS
|
+$4.1M |
| 5 |
Cytokinetics
CYTK
|
+$3.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.56% |
| 2 | Industrials | 17.86% |
| 3 | Technology | 16.26% |
| 4 | Energy | 11.48% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Comstock Resources
CRK
$3.94B
| – | – |
-68,051
| Closed | -$1.18M |
|
|
CSW
277
CSW Industrials
CSW
$5.71B
| – | – |
-9,958
| Closed | -$1.19M |
|
278
CTS Corp
CTS
$1.89B
| – | – |
-75,936
| Closed | -$3.16M |
|
279
CVB Financial
CVBF
$3.99B
| – | – |
-55,915
| Closed | -$1.42M |
|
280
Consolidated Water Co
CWCO
$488M
| – | – |
-133,717
| Closed | -$2.06M |
|
281
Clearway Energy Class C
CWEN
$6.7B
| – | – |
-33,322
| Closed | -$1.06M |
|
|
282
Cytokinetics
CYTK
$10.4B
| – | – |
-77,259
| Closed | -$3.74M |
|
283
Designer Brands
DBI
$333M
| – | – |
-71,114
| Closed | -$1.09M |
|
284
Dycom Industries
DY
$12.3B
| – | – |
-15,128
| Closed | -$1.45M |
|
285
Envela
ELA
$446M
| – | – |
-183,495
| Closed | -$928K |
|
286
Enovix
ENVX
$1.03B
| – | – |
-60,739
| Closed | -$974K |
|
287
Energy Recovery
ERII
$443M
| – | – |
-115,476
| Closed | -$2.51M |
|
288
Evolent Health
EVH
$447M
| – | – |
-80,287
| Closed | -$2.88M |
|
289
Edgewise Therapeutics
EWTX
$4.73B
| – | – |
-122,804
| Closed | -$1.21M |
|
290
Franklin Covey
FC
$246M
| – | – |
-25,138
| Closed | -$1.14M |
|
291
Fluence Energy
FLNC
$2.44B
| – | – |
-129,592
| Closed | -$1.89M |
|
|
FOLD
292
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-168,399
| Closed | -$1.76M |
|
|
FPI
293
Farmland Partners
FPI
$432M
| – | – |
-79,509
| Closed | -$1.01M |
|
294
Geron
GERN
$949M
| – | – |
-416,305
| Closed | -$974K |
|
295
Gossamer Bio
GOSS
$87M
| – | – |
-215,246
| Closed | -$2.58M |
|
296
Graphic Packaging
GPK
$3.58B
| – | – |
-49,192
| Closed | -$971K |
|
|
GTLS
297
DELISTED
Chart Industries
GTLS
| – | – |
-10,812
| Closed | -$1.99M |
|
298
HealthEquity
HQY
$8.75B
| – | – |
-28,103
| Closed | -$1.89M |
|
299
H&R Block
HRB
$5.86B
| – | – |
-36,742
| Closed | -$1.56M |
|
|
STRR
300
Star Equity Holdings
STRR
$41.7M
| – | – |
-38,743
| Closed | -$1.3M |
|
Similar funds
RWM
MCM
HP
OMG
WFAL
WCM
TSS
F1I
EAM Investors's Q4 2022 Portfolio in Review
As of Q4 2022, EAM Investors held 378 positions worth $483M, up 5% from $460M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
EAM Investors withdrew a net $62.1M in Q4 2022, closing 129 positions and reducing 97 holdings. Its most notable exit was Concert Pharmaceuticals, Inc., an estimated $5.93M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.
Against the trend, EAM Investors opened a new position in KLX Energy Services worth $4.07M.
- EAM Investors's largest Q4 2022 buy was KLX Energy Services: 234,913 shares worth $4.07M.
- EAM Investors added most to Modine Manufacturing in Q4 2022, an estimated $1.28M increase.
- EAM Investors's biggest Q4 2022 reduction was Aehr Test Systems, cutting an estimated $3.09M.
- EAM Investors fully exited Concert Pharmaceuticals, Inc. in Q4 2022, selling an estimated $5.93M.
- EAM Investors's ten largest holdings make up 9.9% of its $483M portfolio in Q4 2022.
- EAM Investors opened 132 new positions and closed 129 in Q4 2022.
- EAM Investors's portfolio value rose 5% quarter-over-quarter to $483M.
Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.